NMR based blood tests can detect and differentiate cancer even when a patient is asymptomatic, opening up possibilities of annual checks
For a mixed group of patients referred from primary care with nonspecific signs and symptoms, NMR-based metabolomics can assist their diagnosis. It may differentiate those with malignancies and those with and without metastatic disease. Respectively, the maximum sensitivity and specificity were 94% and 82%. We could also identify patients with metastatic disease in the cohort of patients with cancer with sensitivity and specificity of 94% and 88%, respectively.
Metabolomic Biomarkers in Blood Samples Identify Cancers in a Mixed Population of Patients without Specific Cancer Symptoms